NCT06962670

Predicting Cancer Risk With Digital and Molecular Markers

Digital and Molecular Detection of Markers for Disease Risk Prediction, Improvement of Diagnostic Detection Accuracy and Implementation for Preventive Measures of Cancer - A Combined Case-control and Cohort Study

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,250 (estimated)
• Sponsor: University of Erlangen-Nürnberg Medical School · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The goal of this study is to identify new markers to predict the risk of developing cancer, primarily breast cancer. For this purpose, researchers will compare data obtained from cancer patients and healthy individuals. If characteristic differences are identified, e.g. in biomarkers, life style or family history, this may indicate a person's increased risk of developing cancer.

Conditions

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Gynecologic Cancer

Interventions

Type	Name	Description
OTHER	Biomaterial collection	All subjects will be asked to provide biomaterial (blood or saliva) for bio marker screening and analysis. Additional biomaterial (breath, urin, stool) is optional.
OTHER	BayPass mobile application	All subjects will be asked to use the study-specific mobile application "BayPass" to complete questionnaires and provide results from screening examinations over a course of 12 months.

Timeline

• Start date: 2024-09-14
• Primary completion: 2025-09-01
• Completion: 2025-12-01
• First posted: 2025-05-08
• Last updated: 2025-05-08

Locations

1 site across 1 country: Germany